MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

GlobeNewswire
2025.07.31 13:37
portai
I'm PortAI, I can summarize articles.

NEW YORK, July 31, 2025 ( GLOBE NEWSWIRE ) -- MiNK Therapeutics, Inc. ( NASDAQ: INKT ) , a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T ( iNKT ) cell therapies to treat cancer and ...

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer